Home › Heart Attack › Texas › Houston
Heart Attack clinical trials in Houston, TX
4 studies for Heart Attack are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Clinical Research Strategies, Houston
- DaVita Clinical Research, Houston
- Aqua Research Institute, Houston
- and 4 more
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Baylor College Of Medicine, Houston
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- East Texas Cardiology PA, Houston
- Baylor College of Medicine, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- and 1 more
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
RecruitingObservational study
- MD Anderson Cancer Center, Houston
- Memorial Hermann Texas Medical Center UT Health, Houston
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Detroit, MI4 studies
- Boca Raton, FL4 studies
- Hartford, CT4 studies
- Knoxville, TN4 studies
- Los Angeles, CA4 studies
- Durham, NC3 studies
- Raleigh, NC3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.